Acute management of dengue shock syndrome: a randomized double-blind comparison of 4 intravenous fluid regimens in the first hour.

Dengue hemorrhagic fever is an important cause of morbidity among Asian children, and the more severe dengue shock syndrome (DSS) causes a significant number of childhood deaths. DSS is characterized by a massive increase in systemic capillary permeability with consequent hypovolemia. Fluid resuscitation is critical, but as yet there have been no large trials to determine the optimal fluid regimen. We undertook a randomized blinded comparison of 4 fluids (dextran, gelatin, lactated Ringer's, and "normal" saline) for initial resuscitation of 230 Vietnamese children with DSS. All the children survived, and there was no clear advantage to using any of the 4 fluids, but the longest recovery times occurred in the lactated Ringer's group. The most significant factor determining clinical response was the pulse pressure at presentation. A comparison of the colloid and crystalloid groups suggested benefits in children presenting with lower pulse pressures who received one of the colloids. Further large-scale studies, stratified for admission pulse pressure, are indicated.

[1]  N. M. Dung,et al.  Fluid replacement in dengue shock syndrome: a randomized, double-blind comparison of four intravenous-fluid regimens. , 1999, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[2]  D. Cook,et al.  Crystalloids vs. colloids in fluid resuscitation: a systematic review. , 1999, Critical care medicine.

[3]  D. Gubler,et al.  Dengue and dengue haemorrhagic fever , 1998, The Lancet.

[4]  Duane J. Gubler,et al.  Dengue and Dengue Hemorrhagic Fever , 1998, Clinical Microbiology Reviews.

[5]  G. Schierhout,et al.  Fluid resuscitation with colloid or crystalloid solutions in critically ill patients: a systematic review of randomised trials , 1998, BMJ.

[6]  D. Gubler,et al.  Dengue and dengue hemorrhagic fever. , 2014 .

[7]  S. Bratton,et al.  Colloid volume expanders. Problems, pitfalls and possibilities. , 1998, Drugs.

[8]  F. Sztark,et al.  Effets hémodynamiques des solutions salées hypertoniques , 1997 .

[9]  Eric Boersma,et al.  Early thrombolytic treatment in acute myocardial infarction: reappraisal of the golden hour , 1996, The Lancet.

[10]  M. Rady.  TRIAGE OF CRITICALLY ILL PATIENTS: An Overview of Interventions , 1996 .

[11]  Rady My.  Triage and resuscitation of critically ill patients in the emergency department: current concepts and practice. , 1994 .

[12]  T. Monath,et al.  Dengue: the risk to developed and developing countries. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[13]  S. Rojanasuphot,et al.  Failure of high-dose methylprednisolone in established dengue shock syndrome: a placebo-controlled, double-blind study. , 1993, Pediatrics.

[14]  B. Wagner,et al.  Pharmacologic and clinical considerations in selecting crystalloid, colloidal, and oxygen-carrying resuscitation fluids, Part 1. , 1993, Clinical pharmacy.

[15]  R. Carlson,et al.  Fluid resuscitation in circulatory shock. , 1993, Critical care clinics.

[16]  A. Nisalak,et al.  IgM capture ELISA for detection of IgM antibodies to dengue virus: comparison of 2 formats using hemagglutinins and cell culture derived antigens. , 1992, The Southeast Asian journal of tropical medicine and public health.

[17]  B. Kaufman,et al.  Pharmacology of colloids and crystalloids. , 1992, Critical care clinics.

[18]  M. Haupt,et al.  Fluid resuscitation in patients with increased vascular permeability. , 1992, Critical care clinics.

[19]  P. Senan,et al.  Epidemiology of dengue and dengue haemorrhagic fever in Malaysia. III. A comparative study of clinical features seen in virologically confirmed cases for periods between 1963-1987--a review. , 1992, The Journal of the Singapore Paediatric Society.

[20]  A. Nisalak,et al.  An enzyme-linked immunosorbent assay to characterize dengue infections where dengue and Japanese encephalitis co-circulate. , 1989, The American journal of tropical medicine and hygiene.

[21]  M. Paillard,et al.  Choix des produits de remplissage vasculaire pour le traitement des hypovolémies chez l'adulte , 1989 .

[22]  M. Guzmán,et al.  Dengue haemorrhagic fever/dengue shock syndrome: lessons from the Cuban epidemic, 1981. , 1989, Bulletin of the World Health Organization.

[23]  M. Haupt,et al.  Increased pulmonary edema with crystalloid compared to colloid resuscitation of shock associated with increased vascular permeability. , 1984, Circulatory shock.

[24]  T. Shwe,et al.  Hydrocortisone in the management of dengue shock syndrome. , 1975, The Southeast Asian journal of tropical medicine and public health.

[25]  G. Shires,et al.  The infusion of Ringer's lactate solution during shock. Changes in lactate, excess lactate, and pH. , 1971, American journal of surgery.

[26]  L. Carey,et al.  Electrolyte solutions in resuscitation in human hemorrhagic shock. , 1971, Surgery, gynecology & obstetrics.

[27]  S. Cohen,et al.  Dengue and chikungunya virus infection in man in Thailand, 1962-1964. I. Observations on hospitalized patients with hemorrhagic fever. , 1969 .

[28]  S. Halstead,et al.  Dengue and Chikungunya Virus Infection in Man in Thailand, 1962–1964 , 1969 .

[29]  G. Shires,et al.  Balanced salt solution in the treatment of hemorrhagic shock. Studies in dogs. , 1967, JAMA.